재발성 부인암의 수술적 치료

키워드

참고문헌 (100)

1. Parkin DM, "Estimating the world cancer burden: Globocan 2000", 94(2), pp.153~6 (2001)
2. Landoni F, "Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer", 350(9077), pp.535~40 (1997)
3. Delgado G, "A prospective surgical pathological study of stage I squamous carcinoma of the cervix", pp.314~20
4. Monaghan JM, "Surgical management of advanced and recurrent cervical carcinoma the place of pelvic exenteration", pp.169~82
5. Parkin DM, "Global cancer statistics", 49(1), pp.33~64 (1999)
6. Krebs HB, "Recurrent cancer of the cervix following radical hysterectomy and pelvic node dissection", 59(4), pp.422~7 (1982)
7. "Lanciano R. Radiotherapy for the treatment of locally recurrent cervical cancer", lancia(r), pp.113~5 (1996)
8. Russell AH, "Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract", 27(2), pp.226~32 (1987)
9. Int J Gynecol Cancer 1993, "The role of chemotherapy in squamous cell carcinoma of the uterine cervix", pp.129~42
10. Coleman RL, "Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy", 55(1), pp.29~35 (1994)
11. Goldberg JM, "Improvements in pelvic exenteration factors responsible for reducing morbidity and mortality", pp.399~406 (1998)
12. Hockel M, "Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side wall", pp.369~77 (2003)
13. Hockel M, "Laterally extended endopelvic resectionsurgical treatment of infrailiac pelvic wall recurrences of gynecologic malignancies", pp.2 306~12 (1999)
14. Hockel M, "A novel combined operative and radiotherapeutic treatment approach for recurrent gynecologic malignant lesions infiltrating the pelvic wall", 173(4), pp.297~302 (1991)
15. Hockel M, "Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall", 77(9), pp.1918~33 (1996)
16. Maneo A, "Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy", 9(4), pp.295~301 (1999)
17. Morley GW, "University of Michigan 100 patients at 5 years", pp.934~43
18. Rodriguez Cuevas H, "Pelvic exenteration for carcinoma of the cervix analysis of 252 cases", pp.121~5
19. Rodriguwz-Bigas MA, "Pelvic exenteration and its modifications", 171(2), pp.293~8 (1996)
20. Rubin SC, "Radical hysterectomy for recurrent cervical cancer following radiation therapy", 27(3), pp.316~24 (1987)
21. Rutledge FN, "analysis of 296 patients", pp.881~92
22. Jampolis S, "Analysis of sites and causes of failures of irradiation in invasive squamous cell carcinoma of the intact uterine cervix", 115(3), pp.681~5 (1975)
23. Monaghan J, "Central recurrent cervical cancer: the role of exenterative surgery An atlas of gynecologic oncology", pp.141~51 (2005)
24. Sommers GM, "Outcome of recurrent cervical carcinoma following definitive irradiation", 35(2), pp.150~5 (1989)
25. Brunschwig A, "Complete excision of pelvic viscera for advanced carcinoma A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into colon above the colostomy", pp.177~83
26. Pawlik TM, "Pelvic exenteration for advanced pelvic malignancies", 13(5), pp.612~23 (2006)
27. Shingleton HM, "Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix", 73(6), pp.1027~34 (1989)
28. Soper JT, "factors associated with major surgical morbidity", pp.93~8
29. Kakuda JT, "The role of pelvic exenteration in the management of recurrent rectal cancer", 186(6), pp.660~4 (2003)
30. Morrow C, "Lopez de la Osa E. Surgery for cervical neoplsia.Surgery for cervical neoplsia", pp.451~586 (1996)
31. Manetta A, "a morbidity and mortality analysis of a seven-year experience", pp.219~23
32. Kraybill WG, "Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis", 166(3), pp.259~63 (1988)
33. Garton GR, "Intraoperative radiation therapy in gynecologic cancer", pp.328~32
34. Brunschwig A, "Hemipelvectomy in combination with partial pelvic exenteration for uncontrolled recurrent and metastatic cancer of the cervix", pp.299~304
35. Bricker EM, "Bladder substitution after pelvic evisceration", 30(5), pp.1511~21 (1950)
36. Penalver MA, "Functional characteristics and follow-up of the continent ileal colonic urinary reservoir", pp.4 1667~72
37. Alken P, "100 cases of Mainz pouch", pp.283~8
38. Hatch KD, "Low rectal resection and anastomosis at the time of pelvic exenteration", 31(2), pp.262~7 (1988)
39. Jain AK, "Reconstruction of pelvic exenterative wounds with transpelvic rectus abdominis flaps", pp.115~22 3 (1997)
40. Copeland LJ, "Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenteration", 160(51), pp.1095~101 (1989)
41. Ratliff CR, "Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration", 78(10), pp.2229~35 (1996)
42. Shiromizu K, "A clinicopathological study of postoperative pulmonary metastasis of uterine cervical carcinomas", 25(4), pp.245~9 (1999)
43. Griffiths CT, "Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma", 42, pp.101~4 (1975)
44. Bristow RE, "Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era", pp.1248~59 (2002)
45. McGuire WP, "Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer", 334(1), pp.1~6 (1996)
46. Lopez MJ, "A 50- year experience at the Ellis Fischel Cancer Center", pp.390~5 6
47. Ozols RF, "Recurrent ovarian cancer: evidence-based treatment", pp.1161~3 (2002)
48. Goff B, "Primary Peritoneal CancerControversies in Management Philadelphia", pp.527~38 (2004), Elsevier Ltd
49. Hacker N, "Nonepithelial Ovarian and Fallopian Tube Cancers", (nepithelial ovarian and fallopian tube cancers), pp.511~41 (2005), Lippincott Williams & Wilkins
50. Berek JS, "Survival of patients following secondary cytoreductive surgery in ovarian cancer", 61(2), pp.189~93 (1983)
51. Morris M, "Secondary cytoreductive surgery for recurrent epithelial ovarian cancer", 34(3), pp.334~8 (1989)
52. Janicke F, "Radical surgical procedure improves survival time in patients with recurrent ovarian cancer", 70(8), pp.2129~36 (1992)
53. Segna RA, "Secondary cytoreduction for ovarian cancer following cisplatin therapy", 11(3), pp.434~9 (1993)
54. Vaccarello L, "Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response", 57(1), pp.61~5 (1995)
55. Landoni F, "Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy", 77(2), pp.233~7 (1998)
56. Cormio G,, "Surgical treatment of recurrent ovarian cancer report of 21 cases and a review of the literature", di vag(g) (1999)
57. Zang R, "Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer", 75(1), pp.24~30 (2000)
58. Gadducci A, "Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer", 79(3), pp.344~9 (2000)
59. Eisenkop SM, "The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma", 88(1), pp.144~53 (2000)
60. Munkarah A, "Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer", 81(2), pp.237~41 (2001)
61. Scarabelli C, "Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma", 83(3), pp.504~12 (2001)
62. Tay EH, "Secondary cytoreductive surgery for recurrent epithelial ovarian cancer", 99(6), pp.1008~13 (2002)
63. Zang RY, "Surgery and salvage chemotherapy for Chinese women with recurrent advanced epithelial ovarian carcinoma", pp.419~27 (2003)
64. Zang RY, "Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma", pp.1152~61 (2004)
65. Yoshikawa H, "Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma proposal for patients selection", pp.1026~32 (2005)
66. Gronlund B, "Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum", 31(1), pp.67~73 (2005)
67. Kuhn W, "Disease-adapted relapse therapy for ovarian cancer results of a prospective study", pp.57~63 (1998)
68. Chen LM, "Recurrent ovarian carcinomais there a place for surgery?", pp.62~8 (2000)
69. Chi DS, "Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent" (2006)
70. Pettersson, "Annual Report on the results of treatment in gynecological cancer", 22 (1995)
71. DiSaia PJ, "Risk factors and recurrent patterns in Stage I endometrial cancer", 151(8), pp.1009~15 (1985)
72. Lanciano RM, "The justification for a surgical staging system in endometrial carcinoma", 28(3), pp.189~96 (1993)
73. Moore TD, "Systemic treatment of advanced and recurrent endometrial carcinoma", pp.1071~88
74. Jereczek-Fossa, "Recurrent endometrial cancer after surgery alone results of salvage radiotherapy", pp.405~13 (2000)
75. Wylie J, "Results of radical radiotherapy for recurrent endometrial cancer", 77(1), pp.66~72 (2000)
76. Barakat RR, "Pelvic exenteration for recurrent endometrial cancer", 75(1), pp.99~102 (1999)
77. Morris M, "Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration", 60(2), pp.288~91 (1996)
78. Fiorica JV, "Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma", pp.10~4 (2004)
79. Fleming GF, "Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma", pp.2159~66 (2004)
80. Campagnutta E, "Surgical treatment of recurrent endometrial carcinoma", 100(1), pp.89~96 (2004)
81. Scarabelli C, "Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial carcinoma", 70(1), pp.90~3 (1998)
82. Awtrey CS, "Surgical resection of recurrent endometrial carcinoma" (2006), in press
83. Bristow RE, "Salvage cytoreductive surgery for recurrent endometrial cancer" (2006), in press
84. Omura GA, "A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas", 52(4), pp.626~32 (1983)
85. Sutton G, "Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus", malfeta(jh), pp.226~9 (1996)
86. Sutton GP, "Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus", pp.556~9
87. Wade K, "steroid receptors and response to hormonal therapy", pp.364~7
88. Risch HA, "Differences in risk factors for epithelial ovarian cancer by histologic type Results of a case-control study", pp.363~72 (1996)
89. Rota S, "Behavior of borderline tumors with particular interest to persistence and progression to invasive carcinoma", pp.2658~64 (2001)
90. McCormack PM, "The changing role of surgery for pulmonary metastases", 28(2), pp.139~45 (1979)
91. Levenback C, "Resection of pulmonary metastases from uterine sarcomas", 45(2), pp.202~5 (1992)
92. Gadd MA, "Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma", 218(6), pp.705~12 (1993)
93. Billingsley KG, "Pulmonary metastases from soft tissue sarcoma analysis of patterns of diseases and postmetastasis survival", pp.602~10 2 (1999)
94. Weiser MR, "Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma", pp.~1 (2000)
95. Elias D, "Resection of liver metastases from a noncolorectal primary indications and results based on 147 monocentric patients", pp.487~93 (1998)
96. Leitao MM, "Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma", 87(3), pp.287~94 (2002)
97. Salom EM, "Recurrent vulvar cancer", 3(2), pp.143~53 (2002)
98. Coulter J, "Local and regional recurrence of vulval cancer", pp.663~81 (2003)
99. Maggino T, "Patterns of recurrence in patients with squamous cell carcinoma of the vulva.", 89(1), pp.116~122 (2000)
100. Maggino T, "Patterns of recurrence in patients with squamous cell carcinoma of the vulva.", maggi(t), pp.116 340~22 51, A multicenter CTF Study

관련 논문AI추천